Latest Regulatory News

Riversgold Limited has reported robust gold mineralisation from the final 16 drillholes of its 2025 campaign at the Northern Zone near Kalgoorlie, confirming expansion of the shallow oxide gold footprint. The company is set to commence its 2026 drilling program to further extend the resource.

Forrestania Resources has secured 100% ownership of the Mt Palmer project and adjacent tenements, consolidating its position in Western Australia's Southern Cross and Mt Dimer gold hubs. The acquisition, settled through a substantial share issuance to Newcam Minerals, paves the way for accelerated development towards gold production.

New Frontier Minerals has completed the Stage 1 earn-in to secure an 85% interest in a pivotal tenement at its Harts Range Heavy Rare Earths Project, positioning the company strongly ahead of imminent assay results.

E79 Gold Mines has completed a pivotal high-resolution gravity survey at its Cue Gold Project in Western Australia, setting the stage for targeted drilling and potential high-grade gold discoveries.

TradeWindow Holdings Limited has announced a share purchase plan to raise up to NZ$1 million by issuing new shares to eligible New Zealand and Australian shareholders, opening on 2 February 2026.

TradeWindow has launched a NZ$1 million Share Purchase Plan to accelerate its Freight AI operating system development and support growth across Australasia. This follows a successful NZ$5.7 million placement, signalling strong investor confidence in the company’s tech-driven future.

Santana Minerals has finalized a crucial land access agreement with the Central Otago District Council, paving the way for the Bendigo-Ophir Gold Project to advance pending regulatory approval.

Small caps did the heavy lifting this week, led by two big discovery stories in resources. Funding raises and takeover moves kept attention on who can pay for the next step, not just promise it.

Big moves came from consumer fintech names as investors quickly re-priced growth, losses, and capital needs. A capital-raise week also split the market: some raisings steadied prices, others triggered fresh selling.

Speculative money piled into new discoveries and tight-supply metals, while a handful of small caps were sold hard on thin liquidity. The week’s biggest moves came from PGMs and tungsten on the way up, and micro-cap gas on the way down.

A handful of healthcare names did the heavy lifting this week, driven by FDA wins, guideline upgrades, and big shifts in sales and cashflow. The flip side: several clinical-stage stocks fell hard as investors stayed picky about near-term proof and funding.

Bowen Coking Coal maintained steady production in the December quarter despite ongoing administration and a challenging market, though rising costs and a 12% sales dip highlight operational pressures.